BIO-TECHNE CORP (TECH)

US09073M1045 - Common Stock

73.17  +1.78 (+2.49%)

After market: 73.17 0 (0%)

BIO-TECHNE CORP

NASDAQ:TECH (12/20/2024, 8:00:01 PM)

After market: 73.17 0 (0%)

73.17

+1.78 (+2.49%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS SubIndustryLife Sciences Tools & Services
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%2.44%
Sales Q2Q%4.52%
CRS30.04
6 Month-0.67%
Overview
Earnings (Last)10-30 2024-10-30/bmo
Earnings (Next)01-30 2025-01-30/amc
Ins Owners0.2%
Inst Owners100.25%
Market Cap11.63B
Shares158.89M
PE40.88
Fwd PE32.68
Dividend Yield0.45%
Analysts81.9
Short Float %2.59%
Short Ratio4.44
IPO02-09 1989-02-09
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

TECH Daily chart

Company Profile

Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. The company is headquartered in Minneapolis, Minnesota and currently employs 3,100 full-time employees. The firm's products assist scientific investigations into biological processes and the nature and progress of specific diseases. The Company, in partnership with Wilson Wolf, is creating products such as media and cytokines that are specifically tailored to G-Rex Bioreactors. Its segments include Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, and tissue biopsy analysis.

Company Info

BIO-TECHNE CORP

614 Mckinley Pl N E

Minneapolis MINNESOTA 55413

P: 16123798854

CEO: Charles Kummeth

Employees: 3100

Website: https://www.bio-techne.com/

TECH News

News Image3 days ago - Bio-Techne CorporationBIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the 43rd...

News Image4 days ago - Bio-Techne CorporationBIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a leader in automated platforms for biotherapeutic characterization, today announced a co-marketing and...

News Image5 days ago - Bio-Techne CorporationScaleReady awards a G-Rex® Grant to Moonlight Bio

/PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady, today announced that...

News Image11 days ago - Bio-Techne CorporationBIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and...

News Image13 days ago - Bio-Techne CorporationBIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Asuragen, a Bio-Techne brand, launched a highly sensitive ESR1 mutation monitoring...

News Image25 days ago - Market News VideoKinsale Capital Group Larger Than S&P 500 Component Bio-Techne

TECH Twits

Here you can normally see the latest stock twits on TECH, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example